Home > PS Ratio > GENNEX LABORATORIES

GENNEX LABORATORIES
PS (Price/Sales) Ratio

The Current P/S Ratio of GENNEX LABORATORIES is 5.12.

Share Price ₹15.8Mar 28,2024
Market Cap ₹361.8 Cr
Sales-TTM₹70.7 CrTTM-Consolidated Results
Price/Sales5.12xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for GENNEX LABORATORIES
Please provide your vote to see the results

Definition & Calculation of PS (Price/Sales) ratio of GENNEX LABORATORIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of GENNEX LABORATORIES is calculated as :

Current Market Cap [ ₹361.8 Cr] as on Mar 28,2024

(/) Sales [ ₹70.7 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 5.12x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for GENNEX LABORATORIES , the investors are currently willing to pay '5.12 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of GENNEX LABORATORIES !

The chart below summarizes the trend in P/S Ratio of GENNEX LABORATORIES over the last five years.

Historical PS (Price/Sales) ratio chart of GENNEX LABORATORIES


PS Ratio Performance Analysis for GENNEX LABORATORIES

- GENNEX LABORATORIES 's latest p/e ratio is 5.12x.

- GENNEX LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.01x.

- GENNEX LABORATORIES 's operated at median p/e ratio of 0.83x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GENNEX LABORATORIES 's p/e ratio peaked in Mar2022 at 1.56x.

- GENNEX LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 0.42x.


How does GENNEX LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
GENNEX LABORATORIES 70.75.12361.8
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.68.20388,812.0
CIPLA LTD25,350.24.76120,673.0
DR REDDYS LABORATORIES LTD27,212.53.77102,679.0
ZYDUS LIFESCIENCES LTD19,024.25.32101,152.0
DIVIS LABORATORIES LTD7,492.812.1891,234.9
MANKIND PHARMA LTD9,946.39.2592,029.2
TORRENT PHARMACEUTICALS LTD10,474.08.4188,034.7
LUPIN LTD19,480.13.7873,722.0
AUROBINDO PHARMA LTD27,894.72.2963,835.1
ABBOTT INDIA LTD5,753.49.9557,258.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GENNEX LABORATORIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.29x
Max industry PS 12.18x
Median industry PS 5.32x
Average industry PS 6.64x



You may also like the below Video Courses